Thompson Rubinstein Investment Management Inc. OR held its stake in Colgate-Palmolive Co. (NYSE:CL) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 62,221 shares of the company’s stock at the end of the third quarter. Colgate-Palmolive accounts for about 1.8% of Thompson Rubinstein Investment Management Inc. OR’s portfolio, making the stock its 20th largest position. Thompson Rubinstein Investment Management Inc. OR’s holdings in Colgate-Palmolive were worth $4,613,000 as of its most recent filing with the SEC.

Other large investors also recently bought and sold shares of the company. Fisher Asset Management LLC boosted its stake in shares of Colgate-Palmolive by 3.9% in the third quarter. Fisher Asset Management LLC now owns 24,639 shares of the company’s stock valued at $1,827,000 after buying an additional 918 shares in the last quarter. LGT Capital Partners LTD. boosted its stake in shares of Colgate-Palmolive by 1.8% in the third quarter. LGT Capital Partners LTD. now owns 232,090 shares of the company’s stock valued at $17,207,000 after buying an additional 4,000 shares in the last quarter. Searle & CO. acquired a new stake in shares of Colgate-Palmolive during the third quarter valued at approximately $1,238,000. Advisory Services Network LLC boosted its stake in shares of Colgate-Palmolive by 4.5% in the third quarter. Advisory Services Network LLC now owns 29,725 shares of the company’s stock valued at $2,204,000 after buying an additional 1,270 shares in the last quarter. Finally, Independence Advisors LLC acquired a new stake in shares of Colgate-Palmolive during the third quarter valued at approximately $882,000. Hedge funds and other institutional investors own 71.73% of the company’s stock.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Shares of Colgate-Palmolive Co. (NYSE:CL) traded up 0.15% during mid-day trading on Tuesday, hitting $66.53. 2,674,141 shares of the stock were exchanged. Colgate-Palmolive Co. has a 12-month low of $61.40 and a 12-month high of $75.38. The stock’s 50 day moving average price is $69.68 and its 200-day moving average price is $72.19. The stock has a market capitalization of $59.13 billion, a P/E ratio of 43.51 and a beta of 0.73.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Thursday, October 27th. The company reported $0.73 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.73. The business earned $3.87 billion during the quarter, compared to the consensus estimate of $3.94 billion. Colgate-Palmolive had a net margin of 8.96% and a return on equity of 6,924.14%. The company’s revenue for the quarter was down 3.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.80 EPS. On average, equities research analysts expect that Colgate-Palmolive Co. will post $2.82 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, November 15th. Shareholders of record on Monday, October 24th were given a dividend of $0.39 per share. This represents a $1.56 dividend on an annualized basis and a yield of 2.34%. The ex-dividend date was Thursday, October 20th. Colgate-Palmolive’s dividend payout ratio is presently 101.96%.

COPYRIGHT VIOLATION WARNING: This article was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another publication, it was illegally copied and republished in violation of United States & international copyright & trademark legislation. The original version of this article can be accessed at https://www.thecerbatgem.com/2016/11/29/colgate-palmolive-co-cl-position-held-by-thompson-rubinstein-investment-management-inc-or.html.

Several brokerages have recently commented on CL. B. Riley reiterated a “neutral” rating and set a $78.00 price target on shares of Colgate-Palmolive in a research report on Wednesday, November 2nd. KeyCorp began coverage on shares of Colgate-Palmolive in a research report on Thursday, September 8th. They set a “sector weight” rating for the company. Wells Fargo & Co. reiterated a “market perform” rating on shares of Colgate-Palmolive in a research report on Tuesday, November 15th. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price target for the company in a research report on Monday, October 3rd. Finally, Bank of America Corp. upgraded shares of Colgate-Palmolive from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $70.86 to $80.00 in a research report on Monday, September 12th. Twelve investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $76.04.

In other Colgate-Palmolive news, insider Patricia Verduin sold 3,834 shares of the stock in a transaction that occurred on Monday, October 17th. The shares were sold at an average price of $72.39, for a total transaction of $277,543.26. Following the completion of the sale, the insider now owns 55,013 shares of the company’s stock, valued at approximately $3,982,391.07. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.05% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company’s segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.

5 Day Chart for NYSE:CL

Receive News & Stock Ratings for Colgate-Palmolive Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Co. and related stocks with our FREE daily email newsletter.